Strober B, Tada Y, Mrowietz U, Lebwohl M, et al. Bimekizumab maintenance of response through three years in patients with moderate to severe plaque psoriasis: Results from the BE BRIGHT open-label extension trial. Br J Dermatol 2023 Mar 27:ljad035. doi: 10.1093.
PMID: 36967713